Interest Income, Operating

Name: BioCryst Pharmaceuticals Interest Income, Operating by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BioCryst Pharmaceuticals·Business Segments·1 segment·Rolls up to Total Interest Income

Breakdown

Segment	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$2.52M	$2.24M	$2.89M	$2.26M
Total	—	—	—	—

Segments

Business SegmentsView metric